Right-sizing antibiotic treatment, highlights from the PediSEP-1 kick-off meeting
Penta Young Reporters win “Highly recommended” at PMEA awards
PIPELINE‑RSV International trial achieves first UK green light: St George’s Hospital is activated as the first study site
Trial design and enrolment characteristics of LATA (long-acting treatment in adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa
Household SARS-CoV-2 transmission during Omicron wave in Chiang Mai, Thailand: a prospective observational study
